Optibrium and Lhasa Limited Collaborate to Bring High Level Expert Toxicity Prediction

News   Feb 08, 2013

 
Optibrium and Lhasa Limited Collaborate to Bring High Level Expert Toxicity Prediction
 
 
 

RELATED ARTICLES

Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”

News

Many companies involved in cancer drug research and development need to re-think their use of safety data in helping to bring new drugs to cancer patients.

Dr Richard Knight of ApconiX will tell this month’s conference, that greater focus on pre-clinical safety should be fundamental to the development of new cancer therapies.

READ MORE

Researchers Test Drug Transfer Using Placenta-On-A-Chip

News

Researchers have demonstrated the feasibility of their "organ-on-a-chip" platform in studying how drugs are transported across the human placental barrier.

READ MORE

'Click Chemistry' Reactions Could Boost Cancer-Fighting Drug Potency

News

Researchers at The Scripps Research Institute (TSRI) have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE